Pediatric Endocrinology News

Children with public health insurance may commonly face harmful insurance-related interruptions of continuous glucose monitoring that are not reversed when access is restored, according to a study published in Pediatric Diabetes.

Children with type 1 diabetes who received continued psychological care had a decrease in severe hypoglycemic episodes and stable glycemic control during 2 years of follow up, according to a study published in Pediatric Diabetes.

The frequency of diabetic ketoacidosis among children at type 1 diabetes diagnosis in Germany nearly doubled during the initial COVID-19-related lockdown compared with similar periods in 2018 and 2019, likely due to reduced medical services.

Thyroid-stimulating hormone reference values for children are affected by BMI and ethnicity, and reference values should be individualized accordingly to improve clinical decision-making and reduce unnecessary treatments, study data show.

Thyroid-stimulating hormone reference values for children are affected by BMI and ethnicity, and reference values should be individualized accordingly to improve clinical decision-making and reduce unnecessary treatments, study data show.

The FDA granted clearance for a smart insulin pen to be used by children with diabetes aged at least 7 years, according to an industry press release.

Children with newly diagnosed type 1 diabetes have more abundant gram-negative bacteria in their gut microbiome associated with the onset of disease compared with healthy children, according to an analysis using machine learning algorithms.

Severe obesity starting early in life is a hallmark of rare genetic disorders of obesity. A genetic diagnosis can alleviate feelings of guilt or blame and lessen social stigma for youths with these disorders and their families.

Advantages in bone parameters that may contribute to reduced fracture risk among Black vs. white adolescents and young adults may be attenuated by obesity, according to findings published in Bone.

UnitedHealthcare will now cover Tandem Diabetes’ insulin pumps in network, a reversal of a previous policy that limited pump choices for adults and children with diabetes.